| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |